×ž×“×™× ×”: טייוו×ן
שפה: ×¡×™× ×™×ª
מקור: 衛生ç¦åˆ©éƒ¨é£Ÿå“藥物管ç†ç½² (Ministry of Health and Welfare, Food And Drug Administration)
Daclatasvir Dihydrochloride
臺ç£å¿…治妥施貴寶股份有é™å…¬å¸ å°åŒ—市æ¾å±±å€å¥åº·è·¯156號4樓ã€5樓 (11922609)
J05AP07
膜衣éŒ
Daclatasvir Dihydrochloride (0818005100) (eq to Daclatasvir 30.00 MG)MG
é‹ç®”ç›’è£
製 劑
é ˆç”±é†«å¸«è™•æ–¹ä½¿ç”¨
AstraZeneca Pharmaceuticals LP 4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA US
daclatasvir
é©æ‡‰ç—‡ï¼š1.與sofosbuvir併用,治療æˆäººæ…¢æ€§Cåž‹è‚ç‚ŽåŸºå› åž‹ç¬¬1ã€2ã€3型之感染。2.與asunaprevir併用,治療代償性è‚ç—…(包括è‚硬化)æˆäººæ…¢æ€§Cåž‹è‚ç‚ŽåŸºå› åž‹ç¬¬1b型之感染。3.與asunaprevirã€peginterferonåŠribavirin併用,治療代償性è‚ç—…(包括è‚硬化)æˆäººæ…¢æ€§Cåž‹è‚ç‚ŽåŸºå› åž‹ç¬¬1型之感染。4.與peginterferonåŠribavirin併用,治療æˆäººæ…¢æ€§Cåž‹è‚ç‚ŽåŸºå› åž‹ç¬¬4型之感染。
註銷日期: 2021/01/26; 註銷ç†ç”±: 自請註銷; 有效日期: 2021/01/07; 英文å“å: Daklinza Tablet 30mg
已註銷
2016-01-07
1340869A1 1340869A1 ☤ ⴰ ® åšåœ¡æ‡ž 30 㯒Ⅎ˚0 㯒Ⅎ DAKLINZA ® TABLET PJËšPJ (daclatasvir) 圙徦咣巶⨕䧪 026661 å”☤ ⴰåšåœ¡æ‡ž 30 㪩  圙徦咣巶⨕䧪 026662 å”☤ ⴰåšåœ¡æ‡ž 60 㪩  㗪咣曆ä¯æ©â³©å”“ã‘·á¸¼ä¦ å’£â¿â‹‹ä£¯ DAKLINZA (daclatasvir) 㘖ᷧ䨕⅞檿âºæŸã’®ã€Žä™« HCV æ…䴷㦲嚲䙤 5A (NS5A) 壮 壤 壮 ⯠檻 ㉸ ∠≸˛'DFODWDVYLU dihydrochloride 䙫 ⋽ ⟠ⴠ䂡 carbamic acid, N,N' -[[1,1'-biphenyl]-4,4'-diylbis[1 H -imidazole- 5,2-diyl-(2 S )-2,1-pyrrolidinediyl[(1 S )-1-(1-methylethyl)-2-oxo- 2,1-ethanediyl]]]bis-, C,C' -dimethyl ester, hydrochloride (1:2)Ë› Daclatasvir dihydrochloride ä™«ä´·ã¦²â»¶â¥©á·²Æ CAS ä·å™†Æ â‡â¬·â»¶Æ& 40 H 50 N 8 O .2HCl â‡â¬·æ†¶Æ( 㸟曉⟡ƞGLKydrochloride 湤 ) ⻥䅾奨㓌 Daclatasvir dihydrochloride 䂡䙤剙凚溪剙䱰㜒Æã—ºãºã–£ã°›Ë› DAKLINZA 0 㯒Ⅎ指≸â’㛰䄈㰛Ṛ䲽 (11 㯒Ⅎ )˚⾕ã™ä¹½ä¶”䴇˚ẋå–侎 䔙⟡乽䶔䴇懰˚ṳ㰎⋽䟤˚䡓僩慟æ©âŽ± OPADRY ® % Green 䬰 å³â½‰â‰¸Ë› DAKLINZA 30 㯒Ⅎ指≸â’㛰䄈㰛Ṛ䲽 (58 㯒Ⅎ )˚⾕ã™ä¹½ä¶”䴇˚ẋå–侎 䔙⟡乽䶔䴇懰˚ṳ㰎⋽䟤˚䡓僩慟æ©âŽ± OPADRY ® 03B110005 Green 䬰 å³â½‰â‰¸Ë› OPADRY ® green â’㛰侌Ḁ⟡䔙⟡乽䶔䴇˚ṳ㰎⋽æˆËšåṀṳ慮 400˚棆 ä”喴剙 噆抨湾⟡˚Ọ⎱溪剙㰎⋽æœË› 咣䋄⨶ Ḛä¦ã¤âƒ´ Daclatasvir 㘖ᷧ䨕â–⯴㉾ & â²å‚„äµä–¬ã®¹ä™«ä››ãŽŒá½ƒä”『㉾䖬㮹≸ (D$$Ë› Daclatasvir 㘖 NS5A 䙫㉸âˆâ‰¸Æ16A 㘖ᷧ䨕â¤âŠ†åƒ¤åš²ä™¤å³‘ÆṆ㘖 HCV 壮壤壮â¯æª»ä™«â¾¬å¥¨ä´«ã‡·Ë›Daclatasvir â–㉸âˆä–¬ã®¹ä™« RNA 壮壤ὃä”凮䖬㮹 䱹⬷䴫â¯á½ƒä”˛檻⣽å©æ¨¾å‡®æ›¢å…㨈㓓å©æ¨¾ä™«å²®ã–€æ¡–䤡ÆGDFODWDVYLr 㛪凮 ã‹åš²ä™¤å³‘Ḳ䬓 ⌧ⅎ䙫㰕䫖䙣䔆ẋṹὃä”Æ怀â–僤㛪⯵凛䴷㦲㉔㛙Æâ¾… 俳⹙㓥 NS5A 䙫⊆僤˛ ã…•ä’ƒãªã¯¹â»¥ Daclatasvir 㘖ᷧ䨕⼞㔯䙫㳂⟡⛇ⲠNS5A 壮壤壮â¯æª»ã‰¸âˆâ‰¸Æâ…㛰㔯 㾪⺠ὦ䖬㮹憶㸂⯸ Æ(& 50 ) ‣䂡 pM 凚ἵ nMË›âœâ«âŸ¡â›‡â²ä™«ä´— ×§×¨× ×ת המסמך השל×